APO Research
Talk to an analyst

APO RESEARCH · REPORT

AAT Antibody

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global AAT Antibody Industry Growth and Trends Forecast to 2032

19 December 2025100 pages

Choose your research edition.

Industry ResearchAAT Antibody Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal AAT Antibody Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal AAT Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AAT Antibody Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal AAT Antibody Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global AAT Antibody market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for AAT Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for AAT Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AAT Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of AAT Antibody include Thermo Fisher Scientific, Merck, United States Biological, Signalway Antibody LLC, Santa Cruz Biotechnology, NSJ Bioreagents, LSBio, G Biosciences and Creative Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global AAT Antibody market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The AAT Antibody market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global AAT Antibody market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to AAT Antibody.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global AAT Antibody market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

AAT Antibody Market by Company

Thermo Fisher Scientific

Merck

United States Biological

Signalway Antibody LLC

Santa Cruz Biotechnology

NSJ Bioreagents

LSBio

G Biosciences

Creative Diagnostics

Creative Biolabs

Boster Biological Technology

Abnova

Abcam

AAT Antibody Segment by Type

Polyclonal

Monoclonal

AAT Antibody Segment by Application

Immunohistochemistry Frozen

Enzyme Linked Immunosorbent Assay

Western Blot

Others

AAT Antibody Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AAT Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AAT Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AAT Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of AAT Antibody manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of AAT Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Polyclonal Table 2. Major Company of Monoclonal Table 3. Global AAT Antibody Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global AAT Antibody Sales by Type (2021-2026) & (Kg) Table 5. Global AAT Antibody Sales Market Share in Volume by Type (2021-2026) Table 6. Global AAT Antibody Sales by Type (2021-2026) & (US$ Million) Table 7. Global AAT Antibody Sales Market Share in Value by Type (2021-2026) Table 8. Global AAT Antibody Price by Type (2021-2026) & (US$/Kg) Table 9. Global AAT Antibody Sales by Type (2027-2032) & (Kg) Table 10. Global AAT Antibody Sales Market Share in Volume by Type (2027-2032) Table 11. Global AAT Antibody Sales by Type (2027-2032) & (US$ Million) Table 12. Global AAT Antibody Sales Market Share in Value by Type (2027-2032) Table 13. Global AAT Antibody Price by Type (2027-2032) & (US$/Kg) Table 14. North America AAT Antibody Sales by Type (2021-2026) & (Kg) Table 15. North America AAT Antibody Sales by Type (2021-2026) & (US$ Million) Table 16. Europe AAT Antibody Sales by Type (2021-2026) & (Kg) Table 17. Europe AAT Antibody Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific AAT Antibody Sales by Type (2021-2026) & (Kg) Table 19. Asia-Pacific AAT Antibody Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America AAT Antibody Sales by Type (2021-2026) & (Kg) Table 21. Latin America AAT Antibody Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa AAT Antibody Sales by Type (2021-2026) & (Kg) Table 23. Middle East and Africa AAT Antibody Sales by Type (2021-2026) & (US$ Million) Table 24. AAT Antibody Industry Trends Table 25. AAT Antibody Industry Drivers Table 26. AAT Antibody Industry Opportunities and Challenges Table 27. AAT Antibody Industry Restraints Table 28. Global AAT Antibody Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global AAT Antibody Revenue Market Share by Company (2021-2026) Table 30. Global AAT Antibody Sales by Company (2021-2026) & (Kg) Table 31. Global AAT Antibody Sales Share by Company (2021-2026) Table 32. Global AAT Antibody Market Price by Company (2021-2026) & (US$/Kg) Table 33. Global AAT Antibody Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global AAT Antibody Major Company Production Sites and Headquarters Table 35. Global AAT Antibody Company, Product Type & Application Table 36. Global AAT Antibody Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global AAT Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global AAT Antibody Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global AAT Antibody Sales by Region (2021-2026) & (Kg) Table 41. Global AAT Antibody Sales Market Share in Volume by Region (2021-2026) Table 42. Global AAT Antibody Sales by Region (2021-2026) & (US$ Million) Table 43. Global AAT Antibody Sales Market Share in Value by Region (2021-2026) Table 44. Global AAT Antibody Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 45. Global AAT Antibody Sales by Region (2027-2032) & (Kg) Table 46. Global AAT Antibody Sales Market Share in Volume by Region (2027-2032) Table 47. Global AAT Antibody Sales by Region (2027-2032) & (US$ Million) Table 48. Global AAT Antibody Sales Market Share in Value by Region (2027-2032) Table 49. Global AAT Antibody Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2027-2032) Table 50. Global AAT Antibody Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global AAT Antibody Sales by Application (2021-2026) & (Kg) Table 52. Global AAT Antibody Sales Market Share in Volume by Application (2021-2026) Table 53. Global AAT Antibody Sales by Application (2021-2026) & (US$ Million) Table 54. Global AAT Antibody Sales Market Share in Value by Application (2021-2026) Table 55. Global AAT Antibody Price by Application (2021-2026) & (US$/Kg) Table 56. Global AAT Antibody Sales by Application (2027-2032) & (Kg) Table 57. Global AAT Antibody Sales Market Share in Volume by Application (2027-2032) Table 58. Global AAT Antibody Sales by Application (2027-2032) & (US$ Million) Table 59. Global AAT Antibody Sales Market Share in Value by Application (2027-2032) Table 60. Global AAT Antibody Price by Application (2027-2032) & (US$/Kg) Table 61. North America AAT Antibody Sales by Application (2021-2026) & (Kg) Table 62. North America AAT Antibody Sales by Application (2021-2026) & (US$ Million) Table 63. Europe AAT Antibody Sales by Application (2021-2026) & (Kg) Table 64. Europe AAT Antibody Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific AAT Antibody Sales by Application (2021-2026) & (Kg) Table 66. Asia-Pacific AAT Antibody Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America AAT Antibody Sales by Application (2021-2026) & (Kg) Table 68. Latin America AAT Antibody Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa AAT Antibody Sales by Application (2021-2026) & (Kg) Table 70. Middle East and Africa AAT Antibody Sales by Application (2021-2026) & (US$ Million) Table 71. Thermo Fisher Scientific Company Information Table 72. Thermo Fisher Scientific Business Overview Table 73. Thermo Fisher Scientific AAT Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 74. Thermo Fisher Scientific AAT Antibody Product Portfolio Table 75. Thermo Fisher Scientific Recent Development Table 76. Merck Company Information Table 77. Merck Business Overview Table 78. Merck AAT Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 79. Merck AAT Antibody Product Portfolio Table 80. Merck Recent Development Table 81. United States Biological Company Information Table 82. United States Biological Business Overview Table 83. United States Biological AAT Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 84. United States Biological AAT Antibody Product Portfolio Table 85. United States Biological Recent Development Table 86. Signalway Antibody LLC Company Information Table 87. Signalway Antibody LLC Business Overview Table 88. Signalway Antibody LLC AAT Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 89. Signalway Antibody LLC AAT Antibody Product Portfolio Table 90. Signalway Antibody LLC Recent Development Table 91. Santa Cruz Biotechnology Company Information Table 92. Santa Cruz Biotechnology Business Overview Table 93. Santa Cruz Biotechnology AAT Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 94. Santa Cruz Biotechnology AAT Antibody Product Portfolio Table 95. Santa Cruz Biotechnology Recent Development Table 96. NSJ Bioreagents Company Information Table 97. NSJ Bioreagents Business Overview Table 98. NSJ Bioreagents AAT Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 99. NSJ Bioreagents AAT Antibody Product Portfolio Table 100. NSJ Bioreagents Recent Development Table 101. LSBio Company Information Table 102. LSBio Business Overview Table 103. LSBio AAT Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 104. LSBio AAT Antibody Product Portfolio Table 105. LSBio Recent Development Table 106. G Biosciences Company Information Table 107. G Biosciences Business Overview Table 108. G Biosciences AAT Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 109. G Biosciences AAT Antibody Product Portfolio Table 110. G Biosciences Recent Development Table 111. Creative Diagnostics Company Information Table 112. Creative Diagnostics Business Overview Table 113. Creative Diagnostics AAT Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 114. Creative Diagnostics AAT Antibody Product Portfolio Table 115. Creative Diagnostics Recent Development Table 116. Creative Biolabs Company Information Table 117. Creative Biolabs Business Overview Table 118. Creative Biolabs AAT Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 119. Creative Biolabs AAT Antibody Product Portfolio Table 120. Creative Biolabs Recent Development Table 121. Boster Biological Technology Company Information Table 122. Boster Biological Technology Business Overview Table 123. Boster Biological Technology AAT Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 124. Boster Biological Technology AAT Antibody Product Portfolio Table 125. Boster Biological Technology Recent Development Table 126. Abnova Company Information Table 127. Abnova Business Overview Table 128. Abnova AAT Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 129. Abnova AAT Antibody Product Portfolio Table 130. Abnova Recent Development Table 131. Abcam Company Information Table 132. Abcam Business Overview Table 133. Abcam AAT Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 134. Abcam AAT Antibody Product Portfolio Table 135. Abcam Recent Development Table 136. North America AAT Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 137. North America AAT Antibody Sales by Country (2021-2026) & (Kg) Table 138. North America AAT Antibody Sales Market Share by Country (2021-2026) Table 139. North America AAT Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 140. North America AAT Antibody Sales Market Share Forecast by Country (2027-2032) Table 141. North America AAT Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America AAT Antibody Market Size by Country (2021-2026) & (US$ Million) Table 143. North America AAT Antibody Market Share by Country (2021-2026) Table 144. North America AAT Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America AAT Antibody Market Share Forecast by Country (2027-2032) Table 146. Europe AAT Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 147. Europe AAT Antibody Sales by Country (2021-2026) & (Kg) Table 148. Europe AAT Antibody Sales Market Share by Country (2021-2026) Table 149. Europe AAT Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 150. Europe AAT Antibody Sales Market Share Forecast by Country (2027-2032) Table 151. Europe AAT Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe AAT Antibody Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe AAT Antibody Market Share by Country (2021-2026) Table 154. Europe AAT Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe AAT Antibody Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific AAT Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific AAT Antibody Sales by Country (2021-2026) & (Kg) Table 158. Asia-Pacific AAT Antibody Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific AAT Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 160. Asia-Pacific AAT Antibody Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific AAT Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific AAT Antibody Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific AAT Antibody Market Share by Country (2021-2026) Table 164. Asia-Pacific AAT Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific AAT Antibody Market Share Forecast by Country (2027-2032) Table 166. Latin America AAT Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 167. Latin America AAT Antibody Sales by Country (2021-2026) & (Kg) Table 168. Latin America AAT Antibody Sales Market Share by Country (2021-2026) Table 169. Latin America AAT Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 170. Latin America AAT Antibody Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America AAT Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America AAT Antibody Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America AAT Antibody Market Share by Country (2021-2026) Table 174. Latin America AAT Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America AAT Antibody Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa AAT Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa AAT Antibody Sales by Country (2021-2026) & (Kg) Table 178. Middle East and Africa AAT Antibody Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa AAT Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 180. Middle East and Africa AAT Antibody Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa AAT Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa AAT Antibody Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa AAT Antibody Market Share by Country (2021-2026) Table 184. Middle East and Africa AAT Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa AAT Antibody Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. AAT Antibody Distributors List Table 189. AAT Antibody Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. AAT Antibody Image Figure 2. Global AAT Antibody Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AAT Antibody Market Size (2021-2032) & (US$ Million) Figure 4. Global AAT Antibody Sales (2021-2032) & (Kg) Figure 5. Polyclonal Image Figure 6. Global Polyclonal Sales YoY Growth (2021-2032) & (Kg) Figure 7. Monoclonal Image Figure 8. Global Monoclonal Sales YoY Growth (2021-2032) & (Kg) Figure 9. Global AAT Antibody Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global AAT Antibody Market Share by Type 2025 VS 2032 Figure 11. North America AAT Antibody Sales Market Share in Volume by Type in 2025 Figure 12. North America AAT Antibody Sales Market Share in Value by Type in 2025 Figure 13. Europe AAT Antibody Sales Market Share in Volume by Type in 2025 Figure 14. Europe AAT Antibody Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific AAT Antibody Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific AAT Antibody Sales Market Share in Value by Type in 2025 Figure 17. Latin America AAT Antibody Sales Market Share in Volume by Type in 2025 Figure 18. Latin America AAT Antibody Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa AAT Antibody Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa AAT Antibody Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 AAT Antibody Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Immunohistochemistry Frozen Image Figure 24. Global Immunohistochemistry Frozen Sales YoY Growth (2021-2032) & (Kg) Figure 25. Enzyme Linked Immunosorbent Assay Image Figure 26. Global Enzyme Linked Immunosorbent Assay Sales YoY Growth (2021-2032) & (Kg) Figure 27. Western Blot Image Figure 28. Global Western Blot Sales YoY Growth (2021-2032) & (Kg) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (Kg) Figure 31. Global AAT Antibody Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global AAT Antibody Market Share by Application 2025 VS 2032 Figure 33. North America AAT Antibody Sales Market Share in Volume by Application in 2025 Figure 34. North America AAT Antibody Sales Market Share in Value by Application in 2025 Figure 35. Europe AAT Antibody Sales Market Share in Volume by Application in 2025 Figure 36. Europe AAT Antibody Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific AAT Antibody Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific AAT Antibody Sales Market Share in Value by Application in 2025 Figure 39. Latin America AAT Antibody Sales Market Share in Volume by Application in 2025 Figure 40. Latin America AAT Antibody Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa AAT Antibody Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa AAT Antibody Sales Market Share in Value by Application in 2025 Figure 43. North America AAT Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 44. North America AAT Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America AAT Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America AAT Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe AAT Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 48. Europe AAT Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe AAT Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe AAT Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific AAT Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 52. Asia-Pacific AAT Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific AAT Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific AAT Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America AAT Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 56. Latin America AAT Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America AAT Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America AAT Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa AAT Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 60. Middle East and Africa AAT Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa AAT Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa AAT Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. AAT Antibody Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. AAT Antibody Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Polyclonal
  • Monoclonal
Applications
  • Immunohistochemistry Frozen
  • Enzyme Linked Immunosorbent Assay
  • Western Blot
  • Others
Companies covered
  • Thermo Fisher Scientific
  • Merck
  • United States Biological
  • Signalway Antibody LLC
  • Santa Cruz Biotechnology
  • NSJ Bioreagents
  • LSBio
  • G Biosciences
  • Creative Diagnostics
  • Creative Biolabs
  • Boster Biological Technology
  • Abnova
  • Abcam

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global AAT Antibody Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global AAT Antibody Sales Estimates and Forecasts (2021-2032)
  5. 1.3 AAT Antibody Market by Type
  6. 1.3.1 Polyclonal
  7. 1.3.2 Monoclonal
  8. 1.4 Global AAT Antibody Market Size by Type
  9. 1.4.1 Global AAT Antibody Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global AAT Antibody Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global AAT Antibody Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America AAT Antibody Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe AAT Antibody Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific AAT Antibody Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America AAT Antibody Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa AAT Antibody Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 AAT Antibody Industry Trends
  2. 2.2 AAT Antibody Industry Drivers
  3. 2.3 AAT Antibody Industry Opportunities and Challenges
  4. 2.4 AAT Antibody Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by AAT Antibody Revenue (2021-2026)
  2. 3.2 Global Top Players by AAT Antibody Sales (2021-2026)
  3. 3.3 Global Top Players by AAT Antibody Price (2021-2026)
  4. 3.4 Global AAT Antibody Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global AAT Antibody Major Company Production Sites & Headquarters
  6. 3.6 Global AAT Antibody Company, Product Type & Application
  7. 3.7 Global AAT Antibody Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global AAT Antibody Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 AAT Antibody Players Market Share by Revenue in 2025
  11. 3.8.3 2025 AAT Antibody Tier 1, Tier 2, and Tier 3
4 AAT Antibody Regional Status and Outlook
  1. 4.1 Global AAT Antibody Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global AAT Antibody Historic Market Size by Region
  3. 4.2.1 Global AAT Antibody Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global AAT Antibody Sales in Value by Region (2021-2026)
  5. 4.2.3 Global AAT Antibody Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global AAT Antibody Forecasted Market Size by Region
  7. 4.3.1 Global AAT Antibody Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global AAT Antibody Sales in Value by Region (2027-2032)
  9. 4.3.3 Global AAT Antibody Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 AAT Antibody by Application
  1. 5.1 AAT Antibody Market by Application
  2. 5.1.1 Immunohistochemistry Frozen
  3. 5.1.2 Enzyme Linked Immunosorbent Assay
  4. 5.1.3 Western Blot
  5. 5.1.4 Others
  6. 5.2 Global AAT Antibody Market Size by Application
  7. 5.2.1 Global AAT Antibody Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global AAT Antibody Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global AAT Antibody Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America AAT Antibody Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe AAT Antibody Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific AAT Antibody Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America AAT Antibody Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa AAT Antibody Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Thermo Fisher Scientific
  2. 6.1.1 Thermo Fisher Scientific Company Information
  3. 6.1.2 Thermo Fisher Scientific Business Overview
  4. 6.1.3 Thermo Fisher Scientific AAT Antibody Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Thermo Fisher Scientific AAT Antibody Product Portfolio
  6. 6.1.5 Thermo Fisher Scientific Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck AAT Antibody Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck AAT Antibody Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 United States Biological
  14. 6.3.1 United States Biological Company Information
  15. 6.3.2 United States Biological Business Overview
  16. 6.3.3 United States Biological AAT Antibody Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 United States Biological AAT Antibody Product Portfolio
  18. 6.3.5 United States Biological Recent Developments
  19. 6.4 Signalway Antibody LLC
  20. 6.4.1 Signalway Antibody LLC Company Information
  21. 6.4.2 Signalway Antibody LLC Business Overview
  22. 6.4.3 Signalway Antibody LLC AAT Antibody Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Signalway Antibody LLC AAT Antibody Product Portfolio
  24. 6.4.5 Signalway Antibody LLC Recent Developments
  25. 6.5 Santa Cruz Biotechnology
  26. 6.5.1 Santa Cruz Biotechnology Company Information
  27. 6.5.2 Santa Cruz Biotechnology Business Overview
  28. 6.5.3 Santa Cruz Biotechnology AAT Antibody Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Santa Cruz Biotechnology AAT Antibody Product Portfolio
  30. 6.5.5 Santa Cruz Biotechnology Recent Developments
  31. 6.6 NSJ Bioreagents
  32. 6.6.1 NSJ Bioreagents Company Information
  33. 6.6.2 NSJ Bioreagents Business Overview
  34. 6.6.3 NSJ Bioreagents AAT Antibody Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 NSJ Bioreagents AAT Antibody Product Portfolio
  36. 6.6.5 NSJ Bioreagents Recent Developments
  37. 6.7 LSBio
  38. 6.7.1 LSBio Company Information
  39. 6.7.2 LSBio Business Overview
  40. 6.7.3 LSBio AAT Antibody Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 LSBio AAT Antibody Product Portfolio
  42. 6.7.5 LSBio Recent Developments
  43. 6.8 G Biosciences
  44. 6.8.1 G Biosciences Company Information
  45. 6.8.2 G Biosciences Business Overview
  46. 6.8.3 G Biosciences AAT Antibody Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 G Biosciences AAT Antibody Product Portfolio
  48. 6.8.5 G Biosciences Recent Developments
  49. 6.9 Creative Diagnostics
  50. 6.9.1 Creative Diagnostics Company Information
  51. 6.9.2 Creative Diagnostics Business Overview
  52. 6.9.3 Creative Diagnostics AAT Antibody Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Creative Diagnostics AAT Antibody Product Portfolio
  54. 6.9.5 Creative Diagnostics Recent Developments
  55. 6.10 Creative Biolabs
  56. 6.10.1 Creative Biolabs Company Information
  57. 6.10.2 Creative Biolabs Business Overview
  58. 6.10.3 Creative Biolabs AAT Antibody Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Creative Biolabs AAT Antibody Product Portfolio
  60. 6.10.5 Creative Biolabs Recent Developments
  61. 6.11 Boster Biological Technology
  62. 6.11.1 Boster Biological Technology Company Information
  63. 6.11.2 Boster Biological Technology Business Overview
  64. 6.11.3 Boster Biological Technology AAT Antibody Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Boster Biological Technology AAT Antibody Product Portfolio
  66. 6.11.5 Boster Biological Technology Recent Developments
  67. 6.12 Abnova
  68. 6.12.1 Abnova Company Information
  69. 6.12.2 Abnova Business Overview
  70. 6.12.3 Abnova AAT Antibody Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Abnova AAT Antibody Product Portfolio
  72. 6.12.5 Abnova Recent Developments
  73. 6.13 Abcam
  74. 6.13.1 Abcam Company Information
  75. 6.13.2 Abcam Business Overview
  76. 6.13.3 Abcam AAT Antibody Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Abcam AAT Antibody Product Portfolio
  78. 6.13.5 Abcam Recent Developments
7 North America by Country
  1. 7.1 North America AAT Antibody Sales by Country
  2. 7.1.1 North America AAT Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America AAT Antibody Sales by Country (2021-2026)
  4. 7.1.3 North America AAT Antibody Sales Forecast by Country (2027-2032)
  5. 7.2 North America AAT Antibody Market Size by Country
  6. 7.2.1 North America AAT Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America AAT Antibody Market Size by Country (2021-2026)
  8. 7.2.3 North America AAT Antibody Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe AAT Antibody Sales by Country
  2. 8.1.1 Europe AAT Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe AAT Antibody Sales by Country (2021-2026)
  4. 8.1.3 Europe AAT Antibody Sales Forecast by Country (2027-2032)
  5. 8.2 Europe AAT Antibody Market Size by Country
  6. 8.2.1 Europe AAT Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe AAT Antibody Market Size by Country (2021-2026)
  8. 8.2.3 Europe AAT Antibody Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific AAT Antibody Sales by Country
  2. 9.1.1 Asia-Pacific AAT Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific AAT Antibody Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific AAT Antibody Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific AAT Antibody Market Size by Country
  6. 9.2.1 Asia-Pacific AAT Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific AAT Antibody Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific AAT Antibody Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America AAT Antibody Sales by Country
  2. 10.1.1 South America AAT Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America AAT Antibody Sales by Country (2021-2026)
  4. 10.1.3 South America AAT Antibody Sales Forecast by Country (2027-2032)
  5. 10.2 South America AAT Antibody Market Size by Country
  6. 10.2.1 South America AAT Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America AAT Antibody Market Size by Country (2021-2026)
  8. 10.2.3 South America AAT Antibody Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa AAT Antibody Sales by Country
  2. 11.1.1 Middle East and Africa AAT Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa AAT Antibody Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa AAT Antibody Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa AAT Antibody Market Size by Country
  6. 11.2.1 Middle East and Africa AAT Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa AAT Antibody Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa AAT Antibody Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 AAT Antibody Value Chain Analysis
  2. 12.1.1 AAT Antibody Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 AAT Antibody Production Mode & Process
  7. 12.2 AAT Antibody Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 AAT Antibody Distributors
  10. 12.2.3 AAT Antibody Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst